An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions

Area of Science:

• Molecular Biology
• Genetics
• Synthetic Biology

Background:

• Efficient site-directed insertion of large DNA constructs into genomes is a significant challenge.
• Current methods like recombinases are difficult to program, and CRISPR-Cas systems rely on inefficient host DNA repair.
• There is a need for a robust and programmable system for targeted genomic DNA integration.

Purpose of the Study:

• To develop a novel system for programmable, site-directed genomic DNA insertion.
• To engineer a Cas-Transposon (CasTn) system combining CRISPR-Cas and transposase functionalities.
• To demonstrate the efficiency and programmability of the CasTn system for DNA integration.

Main Methods:

• Fusion of Himar1 transposase to catalytically dead Cas9 (dCas9) to create a CasTn system.
• Utilized cell-free in vitro assays to assess transposon insertion frequency and specificity.
• Tested the system in Escherichia coli for plasmid-based directed transposition.

Main Results:

• The Himar-dCas9 fusion protein significantly increased targeted TA dinucleotide insertion frequency by over 300-fold compared to random transposase.
• Site-directed transposition was dependent on target sequence recognition and robust to variations in protein and DNA concentrations.
• Demonstrated directed transposition into plasmids in E. coli using the Himar-dCas9 system.

Conclusions:

• The Cas-Transposon (CasTn) system provides a new modality for host-independent, programmable, site-directed DNA insertions.
• CasTn overcomes limitations of existing genomic insertion methods by combining targeted DNA binding with efficient transposition.
• This technology offers a powerful tool for synthetic biology, genome engineering, and genetic research.